Levodopa/carbidopa intraduodenal - AbbVie

Drug Profile

Levodopa/carbidopa intraduodenal - AbbVie

Alternative Names: ABT-SLV187; Carbidopa/levodopa enteral suspension; Carbidopa/levodopa intraduodenal; Duodopa; Duopa; LCIG; Levodopa/carbidopa intestinal gel

Latest Information Update: 15 Oct 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator NeoPharma
  • Developer AbbVie
  • Class Antiparkinsonians; Aromatic amino acids; Catecholamines; Hydrazines; Small molecules
  • Mechanism of Action Decarboxylase inhibitors; Dopamine receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Parkinson's disease
  • New Molecular Entity No

Highest Development Phases

  • Marketed Parkinson's disease

Most Recent Events

  • 15 Oct 2018 No development reported - Phase-III for Parkinson's disease (Late-stage disease) in Thailand, South Korea, Japan, Taiwan, New Zealand (Intraduodenal)
  • 14 Sep 2018 Launched for Parkinson's disease (Late-stage disease) in Russia (Intraduodenal)
  • 24 Jun 2018 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top